Effect of Crumble-Pellet and Mash Diets with Different Levels of Dietary Protein and Energy on the Performance of Broilers at the End of the Third Week

This experiment was conducted to investigate the effect of the form of diets with different levels of protein and energy on broilers performance at the end of the third week. A total of 2800 male broiler chicks were fed with two forms of diet (mash and crumble-pellet), two levels of protein (23% and 21% CP), and two levels of energy (3200 and 3000 Kcal/Kg ME) from 1 to 21 days of age. The bodyweight (BW) and Feed conversion rate (FCR) were affected by the form of diet with the crumble-pellet form being better (P < .001). The diet with high protein significantly increased BW and decreased FCR (P < .001). The different levels of energy did not affect FCR and BW in crumble-pellet diet but should a significant effect on them in mash diet (P < .05). There were no significant interactions for any of the parameters tested except for interactions between energy and feed form. BW and FCR were improved by energy when diets were fed in the mash form (unlike the crumble-pellet form) at all ages. It is concluded that feeding crumble-pellets from 1 to 21 days of age improved BW and FCR and that an increase in the protein (unlike energy) content of the diet increased the performance of the chickens at the end of the third week

Association of socioeconomic profiles with cardiovascular risk factors in Iran: The Isfahan Healthy Heart Program

Objectives: To determine the relationship between socioeconomic status (SES) and cardiovascular disease (CVD) risk factors. Methods: A representative sample of adult populations living in three cities in Iran was studied. The demographic and subjective data were collected by questionnaires prepared and validated for this study; physical examination and laboratory tests were conducted under standard protocols. Three components of SES including education, occupation, and income were determined. The univariate ANOVA was used for statistical analysis. Results: The population studied (99.3 response rate) comprised 12,514 subjects (51 females, mean age 38.4 ± 14.3 years). While higher education was a protective factor against smoking in men OR = 0.8 (95 CI = 0.7-0.8), it increased the risk of smoking in women OR = 1.2(95 CI = 1.02-1.5). The other risk factors increased with education especially in men. Higher income level increased the OR of CVD risk factors. Occupation had an inverse association with the aforementioned risk factors. The employed individuals had higher serum lipid level and body mass index than unemployed individual. Conclusion: In line with previous studies, we found an association between SES and CVD risk factors. Education level was the strongest associated factor. © 2010 Swiss School of Public Health

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): A prospective cohort study

Some studies, mainly from high-income countries (HICs), report that women receive less care (investigations and treatments) for cardiovascular disease than do men and might have a higher risk of death. However, very few studies systematically report risk factors, use of primary or secondary prevention medications, incidence of cardiovascular disease, or death in populations drawn from the community. Given that most cardiovascular disease occurs in low-income and middle-income countries (LMICs), there is a need for comprehensive information comparing treatments and outcomes between women and men in HICs, middle-income countries, and low-income countries from community-based population studies. Methods: In the Prospective Urban Rural Epidemiological study (PURE), individuals aged 35–70 years from urban and rural communities in 27 countries were considered for inclusion

Effect of health disorders on the hazard of culling on the first or second lactation in Iranian dairy herds

We conducted a longitudinal retrospective study in order to assess the effect of health disorders (HDs) on culling in the 1st or 2nd lactation cows, in Iranian dairy herds. In total, 7067 first- and second-parity Holstein cows, from 32 Iranian daily herds, which calved from March 2007 to March 2008, were followed until the next calving or culling. Parametric survival models with time-dependent covariates were used to capture the effect of HDs with different duration and recurrence episodes on the risk of culling. Mastitis, locomotor disorders, ovarian cysts, abortion, diarrhea, rumen disorders, displaced abomasum and respiratory disorders were associated with an increased risk of culling. Hazard ratios and 95% confidence intervals were 2.78 (2.31; 335), 3.4(2.79; 4.13) and 1.62 (1.15; 2.78) for mastitis, locomotor disorders and ovarian cysts as common HDs, respectively. Parity and milk-yield were identified as confounder and effect modifier, respectively. The risk of culling in the presence of uterine infection or traumatic reticulo-peritonitis increased with decreasing milk yield. (C) 2012 Elsevier B.V. All rights reserved

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Background Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development. Methods We analysed the availability, costs, and affordability of blood pressure-lowering medicines with data recorded from 626 communities in 20 countries participating in the Prospective Urban Rural Epidemiological (PURE) study. Medicines were considered available if they were present in the local pharmacy when surveyed, and affordable if their combined cost was less than 20% of the households' capacity to pay. We related information about availability and affordability to use of these medicines and blood pressure control with multilevel mixed-effects logistic regression models, and compared results for high-income, upper-middle-income, lower-middle-income, and low-income countries. Data for India are presented separately because it has a large generic pharmaceutical industry and a higher availability of medicines than other countries at the same economic level. Findings The availability of two or more classes of blood pressure-lowering drugs was lower in low-income and middle-income countries (except for India) than in high-income countries. The proportion of communities with four drug classes available was 94% in high-income countries (108 of 115 communities), 76% in India (68 of 90), 71% in upper-middle-income countries (90 of 126), 47% in lower-middle-income countries (107 of 227), and 13% in low-income countries (nine of 68). The proportion of households unable to afford two blood pressure-lowering medicines was 31% in low-income countries (1069 of 3479 households), 9% in middle-income countries (5602 of 65 471), and less than 1% in high-income countries (44 of 10 880). Participants with known hypertension in communities that had all four drug classes available were more likely to use at least one blood pressure-lowering medicine (adjusted odds ratio [OR] 2·23, 95% CI 1·59–3·12); p<0·0001), combination therapy (1·53, 1·13–2·07; p=0·054), and have their blood pressure controlled (2·06, 1·69–2·50; p<0·0001) than were those in communities where blood pressure-lowering medicines were not available. Participants with known hypertension from households able to afford four blood pressure-lowering drug classes were more likely to use at least one blood pressure-lowering medicine (adjusted OR 1·42, 95% CI 1·25–1·62; p<0·0001), combination therapy (1·26, 1·08–1·47; p=0·0038), and have their blood pressure controlled (1·13, 1·00–1·28; p=0·0562) than were those unable to afford the medicines. Interpretation A large proportion of communities in low-income and middle-income countries do not have access to more than one blood pressure-lowering medicine and, when available, they are often not affordable. These factors are associated with poor blood pressure control. Ensuring access to affordable blood pressure-lowering medicines is essential for control of hypertension in low-income and middle-income countries. Funding Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Canadian Institutes of Health Research Strategy for Patient Oriented Research through the Ontario SPOR Support Unit, the Ontario Ministry of Health and Long-Term Care, pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi Aventis [France and Canada], Boehringer Ingelheim [Germany amd Canada], Servier, and GlaxoSmithKline), Novartis and King Pharma, and national or local organisations in participating countries